↓ Skip to main content

Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)

Overview of attention for article published in Psychopharmacology, October 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
128 Mendeley
Title
Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
Published in
Psychopharmacology, October 2013
DOI 10.1007/s00213-013-3288-1
Pubmed ID
Authors

Lynn Taurah, Chris Chandler, Geoff Sanders

Abstract

Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a worldwide recreational drug of abuse. Unfortunately, the results from human research investigating its psychological effects have been inconsistent.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
Unknown 127 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 32 25%
Student > Master 21 16%
Student > Ph. D. Student 19 15%
Researcher 11 9%
Other 7 5%
Other 12 9%
Unknown 26 20%
Readers by discipline Count As %
Psychology 27 21%
Medicine and Dentistry 19 15%
Neuroscience 10 8%
Agricultural and Biological Sciences 8 6%
Nursing and Health Professions 6 5%
Other 25 20%
Unknown 33 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2017.
All research outputs
#6,943,717
of 22,769,322 outputs
Outputs from Psychopharmacology
#1,948
of 5,342 outputs
Outputs of similar age
#63,724
of 210,376 outputs
Outputs of similar age from Psychopharmacology
#18
of 54 outputs
Altmetric has tracked 22,769,322 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 5,342 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,376 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.